Monsanto price target raised to $130-$135 from $118-$120 at Wells Fargo Wells Fargo increased its price target on Monsanto after the company reported higher than expected Q1 EPS. The firm thinks the results "provide a sense of momentum" for the company, and it keeps an Outperform rating on the shares.
News For MON From The Last 14 Days
Check below for free stories on MON the last two weeks.
Tekmira receives $1.5M milestone payment from Monsanto Tekmira Pharmaceuticals (TKMR) announced that it has received a $1.5M milestone payment from Monsanto (MON) following completion of specified program developments. The development milestone is part of the research program under the option agreement Tekmira signed with the agriculture company, which was announced on January 13. The option agreement relates to Tekmira's proprietary delivery technology and intellectual property for use in agricultural applications. The potential value of the transaction could reach up to $86.2M, following the successful completion of all program milestones.